In a large screening aimed at identifying commercially available drugs able to enhance HSPB8 expression in MNs [206], we found colchicine and doxorubicin as capable of counteracting ALS-associated misfolded protein accumulation in a HSPB8-dependent manner. The gene discussed is HSPB8; the disease is amyotrophic lateral sclerosis.